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Abstract
Proteins belonging to Transient Receptor Potential (TRP) family are nonselective 
cation channels that play an essential role in mammalian physiology, functioning as 
transducers of several environmental signals including those of chemical, thermal 
and mechanical natures. A subgroup of these receptors is expressed in sensory 
neurons where they are activated by noxious stimuli and are key players of pain 
responses in the organism. Some TRP channels are molecular targets for the classical 
and non-classical effects of sex steroids. This chapter will describe the close rela-
tionship between nociceptive TRP channels and sex steroids as well as their impact 
on nociception and pain-related responses.
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1. Introduction
The somatosensory system is a complex network of neurons and peripheral 
receptors that encodes specific information about the state of organisms and their 
environment, providing them with the ability to detect harmful stimuli [1–3].
According to the International Association for the Study of Pain (IASP), the 
neuronal process encoding noxious stimuli is known as nociception. A subpopu-
lation of high-threshold sensory neurons known as nociceptors mediates this 
process by detecting harmful signals from chemical and physical nature Figure 1 
[1, 4]. Nociceptors are neurons with a peripheral axonal branch that innervates 
cutaneous, articular and visceral afferents, and a central axonal branch that 
innervates the dorsal horn of the spinal cord. The cell bodies of mammalian 
nociceptors are located in the dorsal root ganglia (DRG) and in the trigeminal 
ganglia (TG) and they are classified as medium and small diameter neurons. The 
axons of these nociceptors are classified as Aδ- and C-fibers depending on their 
diameter, degree of myelinization, conduction speed and the type of sensory 
stimuli that they transmit [1, 4, 5].
The Aδ-fibers are characterized by 2–6 μm diameters, are myelinated and pres-
ent a relatively fast conduction speed between 5 and 30 m/s. The central branch of 
these fibers reaches the superficial laminae of the dorsal horn. These nociceptor 
fibers allow the conduction of cold, pressure and heat signals [5].
Remarkably, C-fibers are the ones to mainly establish nociceptive innervation. 
These are unmyelinated axons with a diameter of 0.4 to 1.2 μm and a conduction 
speed between 0.5 and 2 m/s. C-fibers innervate laminae I and II of the dorsal horn 
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of the spinal cord and are activated in a polymodal fashion by mechanical, thermal 
(noxious cold or heat) and chemical stimuli [4, 5].
Diverse injurious stimuli detected by nociceptors are transformed into electrical 
activity, a process known as transduction where thermal, mechanical, or chemical 
signals are converted into ion flux through the activation of specialized ion channels 
[1]. In this way, noxious signals trigger fluctuations in the electrochemical gradient 
of nociceptors leading to membrane depolarization and subsequent action poten-
tials, as a direct consequence of changes in the activation of ion channels expressed 
in the nociceptors [6]. Action potentials reach second-order neurons housed in the 
superficial laminae of the dorsal horn that project towards the spinothalamic and/or 
spinoparabrachial tracts contributing to the perception of noxious stimuli [2, 3, 7].
The study of the impact of sex steroids on the processing of noxious stimuli has 
been relevant to our understanding of the underlying differences between females 
and males. In the last decades, growing evidence related to sexual dimorphism in 
the perception of harmful signals and the development of pain conditions has been 
highlighted [8]. Several studies in humans using mechanical, chemical, electrical, 
or thermal stimuli have suggested that women have more sensitivity to some nox-
ious stimuli than men [8–11]. However, other contrasting reports have concluded 
that there is no difference in nociception between genders [12, 13]. Even though 
these differences are still not clear, the most reasonable explanation pinpoints 
sex steroids as the most relevant effectors. For example, some conditions such as 
headache, back and temporomandibular pain increase with pubertal development 
in girls, where the gonadal steroids produce crucial changes in women physiology 
[14]. Remarkably, differences in the perception of thermal stimuli between differ-
ent sexes have also been reported, suggesting that women have greater sensitivity to 
heat than men [15]. In relation to this, an epidemiological study indicated that low 
testosterone concentrations in women are associated with an increase in the sensa-
tion of cold [16], clearly suggesting that steroids influence nociception.
Figure 1. 
Nociception. Harmful stimuli are transduced along the terminal axon of specialized pseudounipolar neurons 
(nociceptors), which are classified as unmyelinated C fibers (red) and thinly myelinated Aδ fibers (orange); 
myelinated Aβ fibers (blue) transduce innocuous stimuli. The cell bodies of these peripheral sensory neurons 
are located in the dorsal root ganglia and trigeminal ganglia. Nociceptors innervate the epidermis and viscera, 
transducing noxious stimuli through the activation of several ion channels such as members of the TRP family. 
Finally, the information is transmitted to second order neurons located in the dorsal horn: C fibers and Aδ 
fibers mainly establish contact with neurons from layers I and II, while tactile Aβ fibers end mainly in layers 
III and V.
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2. Nociceptive TRP channels
The functional properties of nociceptors are critically regulated by the activ-
ity of ion channels expressed in their plasma membrane. Some of these channels 
belong to the Transient Receptor Potential (TRP) family that play vital roles as 
detectors of a wide range of biological signals. Some TRP channels are crucial recep-
tors within nociceptors since they function as molecular machinery to transduce 
several noxious sensory stimuli [17].
In mammals, the TRP family consists of 27 members grouped into 6 subfamilies 
based on their sequence homology as follows: TRPC (canonical), TRPV (vanilloid), 
TRPM (melastatin), TRPP (polycystin), TRPML (mucolipin) and TRPA (ankyrin) 
subfamilies. A seventh group is the TRPN (no mechanoreceptor) subfamily which 
is not found in mammals, although it is found in the fruit fly, in C. elegans and 
zebrafish [18]. These receptors are nonselective cation channels that show an overall 
tetrameric structure, with each monomer being a six-pass transmembrane (S1-S6) 
protein with a hydrophilic re-entrant loop between the last two transmembrane 
segments that give rise to the ion conduction pore in the tetrameric arrangement, 
Figure 2. These channels have cytosolic N- and C- termini which are highly variable 
between the different members of the TRP subfamilies [19].
Some TRP channels are expressed in nociceptors where they display essential 
roles in the transduction of several noxious stimuli. Among these nociceptive TRP 
channels are TRPA1, TRPV1–4, TRPM2–3 and TRPM8 [17] which are activated by 
noxious thermal, chemical and mechanical signals and hence they are important 
pain-mediators, Table 1.
The TRPA1 channel, originally described as a cold sensor [20], is activated by 
several external compounds such as isothiocyanates contained in natural products 
such as wasabi, horseradish and mustard oil. Other natural TRPA1 activators are 
allicin and cinnamaldehyde, compounds found in garlic and cinnamon, respectively, 
and acrolein is also an exogenously-found compound that activates this ion channel 
[21–24]. TRPA1’s activation by temperature in humans is still controversial, since 
some reports have described that TRPA1 is an insensitive cold-channel [23, 24], 
Figure 2. 
Overall 3D-structure of a TRP channel. Tetrameric assemble for TRP channels. The colored domains represent 
conserved domains in these channels: Transmembrane domain (S1-S6); the re-entrant loop forms the ion 
conduction pore; the pre-S1 helix joins the N-terminal to the S1; TRP box localized in the C-terminus. TM and 
Cyt: transmembrane and cytosolic regions. (TRPV1 3D- structure, PDB: 3J5P).
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while several experiments have strengthened its role as a cold sensor [21, 25–27]. 
Furthermore, it has also been reported that TRPA1 channel has a redundant role as a 
noxious heat sensor in the mouse [28]. Indeed, this channel is also indirectly acti-
vated by inflammatory mediators like bradykinins and directly by lysophosphatidic 
acid (LPA, a compound released during injury tissue) and some reactive species 
produced as the 4-hydroxynonenal [24, 29, 30]. Thus, TRPA1 activation by these 
endogenous mediators produces inflammatory pain.
Among nociceptive TRP channels some members of the vanilloid recep-
tors (i.e., TRPV1–4 channels) are also included. They are activated by warm 
(TRPV3-V4) to noxious heat (TRPV1-V2) and by several chemical compounds and 
osmotic changes.
The most studied channel of the vanilloid subfamily is the TRPV1 channel, 
originally described as the capsaicin receptor, since it is specifically activated by 
this pungent compound found in chili peppers [31]. This channel is also activated 
by compounds such as allicin, resiniferatoxin (a toxin found in the cactus-like 
plant Euphorbia resinifera) and by animal toxins such as the double-knot (a peptide 
toxin from the Earth Tiger tarantula), among others [31–33]. Additionally, several 
reports have demonstrated that TRPV1 activation is achieved by extracellular acid 
and intracellular basic pHs and heat (≥42°C) [31]. Furthermore, TRPV1 activation 
is produced by diverse compounds released during inflammation and tissue injury, 
for example, some arachidonic acid- and lipoxygenase-derived products, LPA 
and anandamide [34–36]. The high expression of the TRPV1 channel in small and 
medium-diameter neurons and its polymodal activation through several endog-
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TRPV4 30–43°C Osmolality 
(hypo),
Shear stress
Bisandrographolide A 5,6-epoxyeicosatrienoic 
acid
TRPM2 >35°C _ _ Adenosine diphosphate 
ribose, H2O2
TRPM3 ≥40°C Osmolality 
(hypo)
— Pregnenolone sulfate
TRPM8 10–28°C Menthol, Eucalyptol Artemin, Testosterone
Table 1. 
Nociceptive TRP channels and their main activators.
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regulation is a promising field to develop new strategies in the research field of pain 
and analgesia.
The vanilloid subfamily contains two less studied than TRPV1 members: TRPV2 
and TRPV3 channels. The former is expressed in medium- and large DRG neurons, 
activated by temperatures with a threshold of 52°C [37] and by mechanical stretch 
and osmotic swelling [38]; exogenous compounds like some cannabinoids and 
endogenous lipids as lysophosphatidyl choline are also TRPV2 activators [39, 40]. 
Interestingly, the key role of TRPV2 as a noxious sensor is related to mechanical 
nociception in the somatosensory system, where it is required for the detection of 
noxious mechanical stimuli [41].
The TRPV3 channel is expressed in keratinocytes and co-expressed with TRPV1 
channels in small-diameter sensory neurons. This channel is activated by tempera-
tures between 30 and 39°C [42, 43] and camphor and cannabidiol are exogenous 
compounds that are also TRPV3 activators [44, 45]. Interestingly, it has been 
reported that polymorphisms found in the human TRPV2 and TRPV3 genes are 
associated to the susceptibility and severity to fibromyalgia, suggesting the role of 
these channels in chronic pain disorders [46].
The other vanilloid receptor playing a nociceptive role is the TRPV4 channel. 
This channel is activated by warm temperatures (~30–43°C) and hypotonicity 
[47–49]. Among the endogenous compounds that are TRPV4 activators are some 
derivates of arachidonic acid [50, 51]. Interestingly, this ion channel transduces 
osmotic stimuli inducing nociception and it is also an important mediator of the 
pruritogens effects of some compounds like serotonin [52, 53].
Finally, another TRP channels important to nociception are some members of 
the TRPM subfamily: TRPM2-M3 and TRPM8 channels. Although the TRPM2 
channel is mainly expressed in immune cells, some expression has also been 
detected in neurons from DRG and TG [54, 55]. The TRPM2 channel is a warm 
thermo-sensor, since it is activated at 35°C [56]; other activators for this channel 
are adenosine 5′-diphosphoribose (ADPR) and H2O2 [57, 58]. The activation of this 
channel through the generation of reactive species (ROS) implicates it as an impor-
tant mediator of pain perception during stress oxidative conditions, that prevail in 
some conditions as fibromyalgia and neuropathy diabetic [59, 60].
The TRPM3 channel, initially identified in β-pancreatic cells [61] has an important 
role as a sensor of noxious heat, since it is activated by temperatures ≥40°C [62]. The 
activation of this channel can modulate glucose-induced insulin secretion and also 
nociception [61, 62]. Its role in the latter is due to high expression in small-diameter 
sensory neurons from DRG and TG [62] where it also serves as a sensor of noxious 
chemical stimuli to produce painful responses [62, 63]. Remarkably, TRPM3 together 
with TRPA1 and TRPV1 channels, form a redundant trio of sensors that mediates 
noxious heat transduction and provide protection against burn damage [28].
The group of nociceptive TRP channels also comprises the TRPM8 channel, a 
cold-transducer receptor (10–28°C) which is activated by natural compounds as 
menthol [64, 65]. This ion channel is predominantly expressed in a subpopulation 
of small-diameter sensory neurons lacking TRPV1 expression [64, 65]. TRPM8 
overactivation is related to cold allodynia and hypersensitivity, pain caused by 
an innocuous cold stimulus and pain produce by enhanced sensitivity to cold 
stimulus, respectively [66, 67]. Similarly, to other TRP channels, some endog-
enous compounds such as artemin induces pain through TRPM8 activation [66]. 
Curiously, a steroid such as testosterone directly binds to this channel and induces 
its activation [68].
Clearly, the activation of these nociceptive channels is closely related to acute or 
chronic pain development and interestingly, some of these channels are targets for 
sex steroids actions, as we will describe here.
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2.1 Estrogens and nociceptive TRP channels
Estrogens influence sexual differentiation in women and they have other 
essential functions in different biological processes as regulators of the cardiovas-
cular system, metabolism, bone resorption and neuronal physiology [69]. These 
sex steroids comprise estrone (E1) and 17β estradiol (E2) and estriol (E3) [70]. 
Similarly, to other steroids, these estrogen’s actions are exerted by their interaction 
with specific nuclear receptors, the estrogen receptors alpha and beta (ERα and 
ERβ) that act as transcription factors to trigger gene regulation through a classical 
genomic pathway [71]. Furthermore, their actions also are through the activation 
of a membrane localized receptor, the G Protein-Coupled Estrogen Receptor 1 or 
GPER1 (previously named GPR30), establishing a non-classical pathway to regulate 
molecular targets [72, 73]. Several reports have suggested that estrogens influence 
some painful conditions like fibromyalgia, migraine, irritable bowel syndrome and 
temporomandibular disorder, all of which are conditions with major prevalence in 
women than in men [74–78].
Indeed, several experiments made in pain animal models have demonstrated 
the existence of sexual dimorphism in response to pain. For example, rats from a 
diabetic neuropathy model exhibited lower mechanical pain thresholds than males. 
This difference was abolished in gonadectomized animals, highlighting the sex-
related differences in diabetic hypersensitivity [79].
These differences could be attributed to estrogen actions on different targets 
implicated in the transduction of noxious stimuli such as TRP channels, as will be 
described below.
A close relationship between estrogens and the TRPV1 channel has been demon-
strated by several reports. Initially, it was stablished through behavioral assays that 
female rats exhibited increased capsaicin pain-related responses as compared to 
males. Furthermore, ovariectomized rats increased their pain threshold to capsa-
icin, which was reverted by replacement with E2 in these ovariectomized rats [80]. 
E2 effects on the TRPV1 nociception have also been evaluated during the rat estrous 
cycle, where the rats in the proestrus phase showed higher capsaicin-pain responses 
than the rats in estrus. This observation suggested that high E2 levels exhibited in 
the proestrus, positively regulate pain associated to TRPV1 activation [80]. These 
results have also been obtained evaluating the mechanical and thermal pain thresh-
old during the mice estrous cycle, showing that mice in the proestrus displayed 
lower pain thresholds than the mice in estrus [81]. Remarkably, female TRPV1 
knockout mice exhibited comparable mechanical and thermal pain thresholds dur-
ing the proestrus and estrus [81], strongly suggesting that this channel has a pivotal 
role in the transduction of these noxious stimuli and that its activation is regulated 
by estrogen levels. A partial molecular mechanism through which estrogens regu-
late the capsaicin-evoked pain has been described. Initially, it was suggested that 
TRPV1 protein levels are downregulated in the DRG from the ERα and ERβ knock-
out mice-model [82], indicating that this ion channel is a molecular target for the 
effects of estrogen receptors, Figure 3. Furthermore, several reports have evidenced 
that TRPV1 mRNA levels are upregulated by E2. For example, primary cell cultures 
of rat TG or mice DRG neurons treated with E2 displayed increases in TRPV1 
mRNA levels [81, 83]. This TRPV1 mRNA upregulation has also been observed 
in the hippocampus from ovariectomized rats treated with E2, heightening the 
allodynia displayed in a rat inflammatory temporomandibular model [84].
The upregulation on TRPV1 gene expression has been also evidenced in syn-
oviocytes, osteoclast precursors and endometrium [85–87]. Furthermore, experi-
ments performed in cultures of human sensory neurons treated with E2 have 
shown increases in TRPV1 mRNA levels and similar results were obtained when 
7
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the sensory neurons were incubated with a specific agonist of the ERβ [81, 88]. The 
E2-dependent effects in the aforementioned cell systems were observed after 24 h 
of treatment, suggesting that E2 achieves its actions through the classical genomic 
pathway. This possibility is strengthened by the identification of a putative estrogen 
response element (ERE) located in the promoter region of the mouse Trpv1 gene, 
implying that ERα could interact with this gene regulatory sequence to control 
TRPV1 gene transcription [89], Figure 3. These ERα bindings sites were also identi-
fied in the promoter sequences of the Trpv3–6 genes pointing out that estrogens are 
regulators of the transcription of these genes [89]. Additionally, it has been deter-
mined that different areas of the brains of mice in the proestrus (where the estrogens 
levels are high) display augmented mRNA levels for the Trpv2, v4 and v6 genes [89]. 
In contrast, this report also showed that TRPV1 and TRPV5 mRNA levels are down-
regulated in the brain from mice in the proestrus [89].
Additionally, negative E2 effects on TRPV1 activation have been evidenced in 
ovariectomized rats, which displayed reduced production of gonadal estrogens 
and augmented neuronal mitochondrial oxidative stress [90]. This was demon-
strated using primary cultures of hippocampal and DRG neurons from these rats, 
determining that the current densities produced through TRPV1 activation are 
augmented. A similar effect was observed for the TRPA1 and TRPM2 currents [90]; 
Figure 3. 
Schematic representation of the estrogen classical genomic effect in the regulation of TRPV1 gene expression. 
The inactive estrogen receptors (ER) localized in the cytoplasm form a protein complex with the heat shock 
protein (HSP). Internalized 17β estradiol (E2) interacts with the ER, activating and targeting them to the 
nucleus where they recognize the estrogen response element (ERE), a specific sequence located in the target genes 
(i.e., TRPV1 gene), resulting in positive regulation of TRPV1 expression.
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consequently, overactivation of these channels caused rises in cytosolic Ca2+ and 
triggered apoptotic dead of these neurons. These effects were prevented in cultures 
of neurons derived from ovariectomized rats treated with E2 suggesting that this 
steroid could have neuroprotective actions, avoiding Ca2+ overload caused by the 
activation of some nociceptive TRP channels and preventing neuronal death [90].
Negative E2 actions on TRPV1 regulation have also been shown in primary 
cultures of rat DRG neurons treated with E2 or with an ERβ agonist, displaying 
decreases in capsaicin-evoked currents while TRPV1 protein levels remained 
unchanged [91]. This effect was lost using a non-permeable E2 (E2 conjugated 
to bovine serum albumin) and a slight increase in capsaicin-evoked currents was 
observed [91]. This result suggests that the role of E2 on TRPV1 activation requires 
steroid internalization in order to establish an interaction with ERβ and to nega-
tively regulate this ion channel [91]. The discrete increase in TRPV1 activation using 
the non-permeable E2 is in agreement with a previous report which showed that E2 
potentiated capsaicin-induced currents in rat DRG primary cultures [92]. Moreover, 
it was recently described that E2 potentiates TRPV1 activity in an estrogen recep-
tor independent fashion, suggesting that TRPV1 could be an ionotropic receptor 
for E2 [93]. An interesting outcome from these experimental evidences is that the 
changes observed in TRPV1 expression are achieved using low E2 concentrations 
(10–100 nM) [81, 83, 88]; however, the effects on TRPV1 activation need supra-
physiological concentrations of the steroid (1–100 μM) [93, 94]. This suggests that 
low E2 concentrations could modify TRPV1 expression through a classical genomic 
pathway, whereas a non-classical E2 effect on TRPV1 activation requires high E2 
concentrations.
Non-classical E2 actions are produced faster than the genomic effects and are 
mediated by the interaction of this steroid with the GPER1 [72, 73]. The interac-
tion of E2 with this receptor triggers different signaling pathways, such as those 
of protein kinase A (PKA) and C (PKC) [72, 95], which could produce TRPV1 
phosphorylation. The phosphorylated state of the channel decreases its activation 
threshold to several stimuli, a process known as sensitization [96]. For instance, 
a phosphorylated TRPV1 channel can be activated at innocuous heat (i.e., 37°C) 
[96, 97]. TRPV1 phosphorylation also regulates the channel’s interaction with 
proteins like tubulin [98, 99], a protein association that is important to mediate 
mechanical gating of TRPV1 [100]. Interruption of the tubulin-TRPV1 complex 
through the TRPV1 phosphorylation on serine 800 (S800), decreases TRPV1 activa-
tion through osmotic stimuli [99, 100]. Interestingly, E2 through its association with 
GPER1, triggers the activation of PKCε signaling resulting in phosphorylation of 
TRPV1 in S800 and blocking the interaction of the channel with tubulin [99]; thus, 
E2 modifies microtubule-dependent TRPV1 mechanical pain sensitization.
The above data exemplify how TRPV1 is a target of classical and non-classical 
effects of estrogens, highlighting the estrogenic influence on nociception and pain 
mediated through the TRPV1 channel.
2.1.1 Estrogens upregulate TRPA1 and TRPV1 expression in endometriosis
Endometriosis is a debilitating chronic pelvic pain where the lining layer of the 
endometrium grows out of the uterus. This condition is highly estrogen-dependent 
and the lesion displays innervation of nociceptors co-expressing the TRPV1 and 
TRPA1 channels [101, 102]. Interestingly, mRNA levels for TRPA1 and TRPV1 
are upregulated in the biopsies from women with endometriosis [88], thus it is 
feasible to consider that the overexpression of these channels could mediate the 
pain produced in this condition. The overexpression of these channels is likely to 
be through actions of estrogens, since they play a crucial role in the development 
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of this anomalous pelvic condition. Particularly, it has been demonstrated that 
female rats treated with diethylstilbestrol, a non-selective estrogen receptor agonist, 
exhibited upregulation in the TRPV1 and TRPA1 mRNA levels [86] and this expres-
sion was found in endometrial cells. Moreover, cultured primary endometrial cells 
treated with this non-selective agonist also displayed increased TRPA1 and TRPV1 
mRNA levels, whereas the treatment with E2 (which is a highly selective agonist of 
the ERα) only induced the upregulation of the TRPV1 mRNA levels [86]. The data 
suggests that these nociceptive TRP channels are regulated by the classical effects 
of estrogen receptors; additionally, these results showed the expression of these 
channels in non-neuronal cells from the rat endometria. TRPA1 and TRPV1 gene 
expression also has been demonstrated in human endometria from healthy women; 
furthermore, endometria samples from women suffering deep infiltrating endome-
triosis (one of the most severe forms of this condition) exhibit higher TRPV1 and 
TRPA1 expression, as compared to healthy women [103].
Additionally, it has been reported that hydroxylated estrogens (catechol estro-
gens) directly activate the TRPA1 channel [104]. This was evidenced using TRPA1-
expressing HEK293 cells and whole-cell patch-clamp recordings that showed that 
2-hydroxy-estrone (a catechol-estrogen) evoked currents through activation of 
TRPA1, similarly to another agonist for this channel, cinnamaldehyde. Thus, this 
hydroxylated estrogen acts as an endogenous agonist for this nociceptive channel 
[104]. Although, the physiological role of this activation has been demonstrated 
for insulin secretion in β-pancreatic cells, it would be interesting to explore if 
the excessive production of catechol-estrogens in endometriosis (as it has been 
previously reported [105]) affects the function of the TRPA1 channel expressed in 
endometrial cells and in the free nerve terminals surrounding this area. The expres-
sion of these channels in endometrial cells could represent a therapeutic alternative 
to relieve the main symptoms related to this painful condition; thus, it would be 
relevant to deepen the studies about the functional roles of TRP channels in these 
non-neuronal cells.
In addition to the above described evidence, the roles of TRPA1 and TRPV1 in 
endometriosis have been recently strengthened through the establishment of a 
mouse endometriosis model [106]. The endometriosis-like lesions induced in these 
animals displayed the presence of nerve fibers and inflammatory cells around the 
lesions. Remarkably, theses nerve fibers showed expression of TRPA1 and TRPV1 
channels [106]. Furthermore, DRG neurons isolated from mice with induced 
endometriosis exhibited higher Ca2+ influx levels than neurons from sham animals, 
and this effect was through the activation of TRPA1 or TRPV1 channels [106]. 
The upregulation of these nociceptive channels could be directly associated with 
spontaneous abdominal pain observed in mice with endometriosis. Interestingly, 
the treatment of these mice with a synthetic androgen (danazol) or an aromatase 
inhibitor (letrozole), which are estrogen reducing agents, substantially relieved the 
spontaneously induced endometriosis pain [106]. These data reinforce the crucial 
role of estrogens in the development of endometriosis and highlight the importance 
of the TRPA1 and TRPV1 channels as molecular pain mediators in this debilitating 
form of abdominal pain.
2.2 Nociceptive TRP channels that are targeted by androgen actions
Androgens are steroids that influence the development of male characteristics 
and they are produced in the gonads (testicles and ovaries) and adrenal glands 
[107]. The main endogenously produced androgens are testosterone, androstene-
dione, dehydroepiandrosterone (DHEA) and dihydrotestosterone (DHT) [108]. 
Similarly, to other steroids, testosterone and DHT act as ligands for a specific 
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protein, such as the androgen receptor (AR), while other androgens are weak 
ligands of the AR. This receptor regulates the expression of several target genes 
through a classical genomic pathway; furthermore, AR modifies cell physiology 
through non-classical and non-genomic effects [109].
Indeed, some androgens produce fast- non-genomic effects by interacting with 
other proteins like some TRP channels and modulating their function. For example, 
through whole-cell recording electrophysiological experiments, DHEA was shown 
to decrease capsaicin-dependent currents in dissociated DRG neurons [110]. DHEA 
effects seem to be direct and specific on TRPV1 channel activation, since with the 
use of a DHEA stereoisomer the inhibition of channel activation was no longer 
observed. Additionally, testosterone reduced the activation of TRPV1 to a lesser 
extent than DHEA [110]. This suggested the presence of a DHEA-binding site in 
the TRPV1 channel, which should be extracellularly localized, since the steroid was 
applied to the surface of the neurons during the electrophysiological recordings 
[110]. However, this remains undetermined and it is possible that DHEA has an 
antinociceptive role by inhibiting this channel.
The above data exemplified the rapid non-genomic effects of DHEA on TRPV1 
activation. Additionally, testosterone seems to negatively regulate the expression 
of this channel, suggesting that TRPV1 is also a target for the classical actions of 
androgens. Supporting evidence for this was obtained in dissected TG from cas-
trated male rats with orofacial myositis (induced by the Complete Freund’s adju-
vant) [111]. The trigeminal TRPV1 mRNA and protein levels from this rat model 
were upregulated. Interestingly, TRPV1 expression is unaffected in the TG from 
castrated rats subjected to testosterone replacement [111], suggesting that testoster-
one prevents the increase in TRPV1 expression, although the molecular mechanism 
for this regulation is still unknown.
The TRPA1 channel is another molecular target for the non-classical effects 
of androgens. As a first approach, it was demonstrated that synthetic aromatase 
inhibitors evoked currents through TRPA1 channels in isolated DRG neurons; 
however, these compounds were unable to produce currents in DRG neurons from 
TRPA1 knockout mice, suggesting specific actions of the aromatase inhibitors on 
the activation of this channel [112]. Indeed, it was demonstrated that the aroma-
tase inhibitors produced pain-like behavior in mice, a conduct not displayed in the 
TRPA1 knockout mice [112]. Since these compounds increase the levels of andro-
stenedione in plasma, the effects of this androgen on TRPA1 activation have also 
been studied [113]. The results showed that androstenedione produces currents 
in mouse DRG neurons that are partially dependent on TRPA1 activation [113]. 
Furthermore, remanent androstenedione currents were abolished in the pres-
ence of the TRPV1 antagonist capsazepine, suggesting that this androgen could 
activate nociceptive TRPA1 and TRPV1 channels. Although, androstenedione is 
unable to cause acute pain-like behavior in mice, the animals exhibited mechani-
cal allodynia 30 to 120 min after its intradermal injection into their paws, an 
effect that was abolished with a TRPA1 antagonist [113]. These data indicate that 
androstenedione could act as a pain sensitizing molecule leading to the activation 
of TRPA1.
Finally, the TRPM8 channel is also regulated by androgens. Interestingly, this 
channel is a target for the classical and nonclassical actions of testosterone. Initial 
evidence showed that TRPM8 is an androgen-responsive gene since testosterone 
treatment in some prostate cancer cell lines produced upregulation in the TRPM8 
mRNA levels [114, 115]. TRPM8 expression also increases in the urogenital tract 
from orchiectomized rats supplemented with testosterone, suggesting that this 
steroid positively regulates TRPM8 gene expression [116]. Bioinformatic gene 
analysis showed that the TRPM8 gene contains putative sites for the androgen 
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receptor interaction (androgen response elements, ARE) in its promoter sequence. 
Through chromatin-immunoprecipitation assays, it was confirmed that androgens 
receptors bind to these AREs located near the start transcription site of the TRPM8 
gene [117]. These data indicated that androgens regulate TRPM8 gene expression in 
a classical genomic fashion.
The TRPM8 channel also acts as an ionotropic testosterone receptor due to direct 
interaction with this ion channel, resulting in its activation [68, 118]. Experiments 
have shown that the TRPM8 channel and the androgen receptor compete for 
testosterone and dihydrotestosterone because activation of TRPM8 by these andro-
gens is lost when both receptors are co-expressed [68]. An extracellularly-located 
testosterone binding site in the TRPM8 channel has been suggested [68], and by 
using molecular docking simulation we have identified an additional intracellular 
testosterone pocket located between the firts intracellular loop (pre-S1) and the 
transmembrane segments 1 and 2 (S1-S2) of the TRPM8 protein [119]. This analysis 
has also shown that an H-bond is formed between testosterone and an arginine 
located in the TRP box, similar to the H-bond established between testosterone 
and an arginine in the aromatase enzyme [119]. The similarity in the testosterone 
pockets of the aromatase and the TRPM8 proteins could suggest that this is a 
functional binding site for TRPM8 through which activation by this steroid could be 
achieved in a non-classical and fast fashion. Interestingly, it has been demonstrated 
that topic testosterone application on humans produced cold- and pain-sensation; 
the women resulted more sensitized to the testosterone effects than men [68], sug-
gesting a sexual dimorphism in testosterone-produced nociception through TRPM8 
activation.
A third non-classical mechanism for TRPM8 regulation by testosterone has 
been demonstrated in DRG neurons where the androgen receptor and TRPM8 
channels form a protein complex in the plasma membrane [120]. High testosterone 
concentrations (100 nM) inhibit TRPM8 channel activation and the androgen 
receptor is translocated to the nucleus [120], Figure 4. The evaluation of the 
TRPM8-mediated cold perception performed in castrated mice or rats revealed a 
decrease in their threshold for mild-cold perception; interestingly, testosterone 
Figure 4. 
Testosterone regulates the TRPM8-mediated mild-cold sensitivity. The mild-cold stimulus is transduced through 
the TRPM8 channel located in the cell surface of DRG neurons where it forms a protein complex with the 
androgen receptor (AR) (upper panel). A high concentration of testosterone (100 nM) decreases activation of 
the TRPM8 channel and produces translocation of the AR to the nucleus. The physiological consequence of this 
is the loss of the mild cold sensation (lower panel).
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supplementation in these animals inhibited cold perception (temperatures 
between 16 and 18°C) [120]. This result would suggest that testosterone confers 
endurance to TRPM8-mediated mild cold perception, which could explain the 
underlying molecular mechanism for the cold sensation experienced by women 
presenting lower levels of testosterone [16].
2.3 Progesterone downregulates TRPV1 and TRPV4 channels expression
Progesterone is a steroid indispensable to the maintenance of pregnancy and 
it also plays important roles in the cardiovascular, immune, nervous systems and 
in the bones [121]. Progesterone is produced by the granulosa cells and the corpus 
luteum in the ovaries and, during pregnancy, the placenta is the major source of 
this steroid. Additionally, progesterone is produced in the nervous system, adrenal 
glands and testes [122]. The effects of progesterone are produced through nuclear 
receptors A and B (PRA/B), activating the classical genomic pathway to regulate 
gene expression. Furthermore, this steroid exerts a non-classical pathway through 
the activation of several membrane receptors (mPR) and other receptors as the 
progesterone receptor membrane components 1 and 2 (PGRMC1/2) and by the 
Sigma-1 Receptor (Sig-1R) [123, 124].
It has been demonstrated that progesterone regulates the expression of some 
TRP channels; for example, TRPV4 gene expression is negatively regulated by clas-
sical genomic progesterone effects [125]. Initial evidence for this was observed in 
epithelial and vascular cell lines and a recent report showed a correlation between 
TRPV4 expression and progesterone levels during the menstrual cycle, demonstrat-
ing that during the luteal phase when progesterone reaches its highest levels, TRPV4 
expression is downregulated in human endometrial biopsies [126]. Furthermore, 
it has also been reported that TRPV4 expression is downregulated by a synthetic 
progestin (levonorgestrel) in a human Fallopian tubal epithelial cell line and mouse 
oviducts which could affect the transport of fertilized oocytes causing ectopic 
pregnancy [127].
Our group has determined that progesterone impacts on nociception by regulat-
ing the expression of TRPV1 channels [128]. Interestingly, this regulation is through 
a non-classical mechanism that requires an intermediate protein, the Sig-1R, 
which is a dynamic chaperone mainly localized in the endoplasmic reticulum and 
that can also be mobilized to the plasma membrane and nuclear envelope [129]. 
Progesterone decreases the levels of channels localized in the cell surface in HEK293 
cells transfected with TRPV1 cDNA [128]. But how does progesterone produce this 
effect? Our results have shown that this is achieved by disrupting a protein com-
plex formed between TRPV1 channels and the Sig-1R and by affecting the proper 
folding of TRPV1. Consequently, the channels are degraded by the proteasomal 
pathway and capsaicin-evoked currents are reduced [128]. The TRPV1 downregula-
tion through progesterone actions was also observed in primary cultures of DRG 
neurons and we also demonstrated that during mice pregnancy when there are 
high progesterone levels, the threshold to capsaicin-dependent pain-like behaviors 
are augmented in comparison to non-pregnant mice, suggesting that progesterone 
confers protection to pain produced through activation of TRPV1 [128]. This 
work exemplified the antinociceptive actions that progesterone exerts through 
the decrease in the levels of TRPV1 channels localized in the plasma membrane of 
nociceptors and by the reduction of the transduction of harmful signals through 
this ion channel. Moreover, it has also been reported that progesterone disrupts 
the protein complex formed between Sig-1R and the TRPA1 and TRPM8 channels 
[130], suggesting that this steroid could impact the nociception through these 
nociceptive TRP channels.
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3. Conclusion
Nociception is a neuronal process that protects against injurious stimuli that can 
be endogenously produced during inflammation or tissue injury processes. The trans-
duction of these signals requires the activation of ion channels such as some members 
of the TRP family. In this chapter we have described how sex steroids influence noci-
ception by regulating some of the TRP channels important for this neuronal process. 
Here we have described the data showing that estrogens and their nuclear receptors 
(ERα/β) positively regulate the expression of the TRPV1 and TRPA1 genes through a 
classical genomic pathway. The reports above discussed also show that progesterone 
and its nuclear receptors (PRA/B) negatively regulate TRPV4 gene expression.
We have also compiled and discussed the evidence about androstenedione’s and 
testosterone’s non-classical effects in the regulation of the activation of TRPA1 and 
TRPM8 ion channels directly. We have suggested a testosterone binding-pocket 
in the TRPM8 channel and we have also pinpointed an androstenedione binding-
pocket in the C-terminal and pre-S1 regions of TRPV1 and TRPA1 channels [119].
These observations strengthen the notion that androgens act as direct molecular 
regulators of some nociceptive ion channels function, playing dual roles as nociceptive 
and antinociceptive molecules. For example, androstenedione has nociceptive actions 
on TRPA1 and TRPV1 activation and testosterone at low concentrations (picomolar 
range) can produce cold sensation through the TRPM8 channel, while high testoster-
one levels could improve resilience to cold sensation inhibiting the currents through 
TRPM8. Finally, the literature here reviewed shows that the nonclassical sex steroid 
effects are mediated by membrane receptors or even chaperones such as the Sig-1R, 
affecting signaling pathways and/or protein stability. This last finding exemplifies the 
antinociceptive effects of progesterone by which this hormone reduces the transduc-
tion of noxious stimuli mediated by TRPV1 channel activation. These data open a 
research field in which we will deepen our knowledge in the role of molecular sexual 
dimorphism and the interplay between nociceptive TRP channels and sex steroids.
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